Company rebrand to focus the scientific story and step into the industry spotlight.
Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Rebrand to usher in the next phase of the C4 Therapeutics story.
Re-imagined brand identity supports immuno-oncology company’s march to the clinic
A clinical-stage debut for a precision player in the neuro space
New company name and brand identity support a vision fueled by optimism
Setting the stage for a gene therapy clinical trial in children
